Tucotuzumab Celmoleukin (EPCAM/CD326) - Research Grade Biosimilar
Gecertificeerd

Tucotuzumab Celmoleukin (EPCAM/CD326) - Research Grade Biosimilar

Catalog #: 10-272
Maat: 0.1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

Tucotuzumab celmoleukin is under investigation in clinical trial NCT00016237 (Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment) .

Immunogen

Humanized / EPCAM/CD326 [Homo sapiens]

Clonality

• Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Cancer

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Fragment

IgG1-nd

NCBI Organism

Homo sapiens

Other Product Names

EMD 273066, KSA-Interleukin-2, huKS-IL2, huKS1/4-IL-2

Beschrijving

Tucotuzumab Celmoleukin (EPCAM/CD326) - Research Grade Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamTucotuzumab Celmoleukin (EPCAM/CD326) - Research Grade Biosimilar
Categorie
Beschikbare grootte0.1 mg
Catalogusnummer10-272